Liddiard Kate, Welch John S, Lozach Jean, Heinz Sven, Glass Christopher K, Greaves David R
Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.
BMC Mol Biol. 2006 Nov 29;7:45. doi: 10.1186/1471-2199-7-45.
Macrophages (Mtheta) play a central role in the innate immune response and in the pathology of chronic inflammatory diseases. Macrophages treated with Th2-type cytokines such as Interleukin-4 (IL-4) and Interleukin-13 (IL-13) exhibit an altered phenotype and such alternatively activated macrophages are important in the pathology of diseases characterised by allergic inflammation including asthma and atopic dermatitis. The CC chemokine Thymus and Activation-Regulated Chemokine (TARC/CCL17) and its murine homologue (mTARC/ABCD-2) bind to the chemokine receptor CCR4, and direct T-cell and macrophage recruitment into areas of allergic inflammation. Delineating the molecular mechanisms responsible for the IL-4 induction of TARC expression will be important for a better understanding of the role of Th2 cytokines in allergic disease.
We demonstrate that mTARC mRNA and protein are potently induced by the Th2 cytokine, Interleukin-4 (IL-4), and inhibited by Interferon-gamma (IFN-gamma) in primary macrophages (Mtheta). IL-4 induction of mTARC occurs in the presence of PI3 kinase pathway and translation inhibitors, but not in the absence of STAT6 transcription factor, suggesting a direct-acting STAT6-mediated pathway of mTARC transcriptional activation. We have functionally characterised eleven putative STAT6 sites identified in the mTARC proximal promoter and determined that five of these contribute to the IL-4 induction of mTARC. By in vitro binding assays and transient transfection of isolated sites into the RAW 264.7 Mtheta cell-line, we demonstrate that these sites have widely different capacities for binding and activation by STAT6. Site-directed mutagenesis of these sites within the context of the mTARC proximal promoter revealed that the two most proximal sites, conserved between the human and mouse genes, are important mediators of the IL-4 response.
The induction of mTARC by IL-4 results from cooperative interactions between STAT6 sites within the mTARC gene promoter. Significantly, we have shown that transfer of the nine most proximal mTARC STAT6 sites in their endogenous conformation confers potent (up to 130-fold) IL-4 inducibility on heterologous promoters. These promoter elements constitute important and sensitive IL-4-responsive transcriptional units that could be used to drive transgene expression in sites of Th2 inflammation in vivo.
巨噬细胞(Mθ)在先天性免疫应答及慢性炎症性疾病的病理过程中发挥核心作用。用白细胞介素-4(IL-4)和白细胞介素-13(IL-13)等Th2型细胞因子处理的巨噬细胞表现出改变的表型,这种替代性活化的巨噬细胞在以过敏性炎症为特征的疾病(包括哮喘和特应性皮炎)的病理过程中很重要。CC趋化因子胸腺和活化调节趋化因子(TARC/CCL17)及其小鼠同源物(mTARC/ABCD-2)与趋化因子受体CCR4结合,并直接将T细胞和巨噬细胞募集到过敏性炎症区域。阐明负责IL-4诱导TARC表达的分子机制对于更好地理解Th2细胞因子在过敏性疾病中的作用至关重要。
我们证明,在原代巨噬细胞(Mθ)中,Th2细胞因子白细胞介素-4(IL-4)可有效诱导mTARC mRNA和蛋白表达,而干扰素-γ(IFN-γ)则可抑制其表达。mTARC的IL-4诱导在PI3激酶途径和翻译抑制剂存在的情况下发生,但在没有STAT6转录因子的情况下则不发生,这表明mTARC转录激活存在直接作用的STAT6介导途径。我们对在mTARC近端启动子中鉴定出的11个假定的STAT6位点进行了功能表征,并确定其中5个位点对mTARC的IL-4诱导有贡献。通过体外结合试验以及将分离的位点瞬时转染到RAW 264.7 Mθ细胞系中,我们证明这些位点对STAT6的结合和激活能力差异很大。在mTARC近端启动子背景下对这些位点进行定点诱变表明,人类和小鼠基因之间保守的两个最近端位点是IL-4应答的重要介导因子。
IL-4对mTARC的诱导是由mTARC基因启动子内STAT6位点之间的协同相互作用导致的。重要的是,我们已经表明,九个最近端的mTARC STAT6位点以其内源构象转移可赋予异源启动子强大的(高达130倍)IL-4诱导能力。这些启动子元件构成了重要且敏感的IL-4应答转录单元,可用于在体内Th2炎症部位驱动转基因表达。